AR054291A1 - Replicas compactas de virus de epstein-barr - Google Patents

Replicas compactas de virus de epstein-barr

Info

Publication number
AR054291A1
AR054291A1 ARP980102555A ARP980102555A AR054291A1 AR 054291 A1 AR054291 A1 AR 054291A1 AR P980102555 A ARP980102555 A AR P980102555A AR P980102555 A ARP980102555 A AR P980102555A AR 054291 A1 AR054291 A1 AR 054291A1
Authority
AR
Argentina
Prior art keywords
replies
barr
epstein
virus
compact
Prior art date
Application number
ARP980102555A
Other languages
English (en)
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of AR054291A1 publication Critical patent/AR054291A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se revelan secuencias de ácido nucleico que soportan réplica episomica en una célula mamífera. Estas secuencias de ácido nucleico, que tienen una longitud de menos de 3 kb, incluyen (a) una secuencia OriP suprimida y (b) una secuencia EBAN1 suprimida enlazada operativamente con un promotor.
ARP980102555A 1997-06-19 1998-06-01 Replicas compactas de virus de epstein-barr AR054291A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5020697P 1997-06-19 1997-06-19

Publications (1)

Publication Number Publication Date
AR054291A1 true AR054291A1 (es) 2007-06-20

Family

ID=21963948

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102555A AR054291A1 (es) 1997-06-19 1998-06-01 Replicas compactas de virus de epstein-barr

Country Status (20)

Country Link
US (1) US6133025A (es)
EP (1) EP1032418B1 (es)
JP (1) JP2002505586A (es)
KR (1) KR100569826B1 (es)
CN (1) CN1263861C (es)
AR (1) AR054291A1 (es)
AT (1) ATE270341T1 (es)
AU (1) AU744680B2 (es)
BR (1) BR9810055A (es)
CA (1) CA2293299A1 (es)
DE (1) DE69824881T2 (es)
DK (1) DK1032418T3 (es)
ES (1) ES2224382T3 (es)
HU (1) HUP0003971A3 (es)
ID (1) ID24649A (es)
PL (1) PL337528A1 (es)
PT (1) PT1032418E (es)
RU (1) RU2240348C2 (es)
TR (1) TR199903155T2 (es)
WO (1) WO1998057658A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE389022T1 (de) * 2001-05-07 2008-03-15 Ca Nat Research Council Verstärkte herstellung rekombinanter proteine mittels transienter transfektion von in suspension wachsenden säugerzellen
WO2009137911A1 (en) 2008-05-15 2009-11-19 National Research Counsil Of Canada Process, vectors and engineered cell lines for enhanced large-scale transfection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939088A (en) * 1987-02-18 1990-07-03 Meloy Laboratories Inc. Sustained production of recombinant gamma interferon using an Epstein-Barr virus replicon

Also Published As

Publication number Publication date
US6133025A (en) 2000-10-17
HUP0003971A2 (en) 2001-03-28
AU7123998A (en) 1999-01-04
RU2240348C2 (ru) 2004-11-20
JP2002505586A (ja) 2002-02-19
WO1998057658A1 (en) 1998-12-23
PT1032418E (pt) 2004-10-29
CN1263861C (zh) 2006-07-12
KR100569826B1 (ko) 2006-04-11
TR199903155T2 (en) 2000-09-21
DK1032418T3 (da) 2004-11-01
BR9810055A (pt) 2000-09-12
CN1278185A (zh) 2000-12-27
ID24649A (id) 2000-07-27
DE69824881T2 (de) 2004-11-18
EP1032418A1 (en) 2000-09-06
ES2224382T3 (es) 2005-03-01
DE69824881D1 (de) 2004-08-05
PL337528A1 (en) 2000-08-28
HUP0003971A3 (en) 2003-03-28
AU744680B2 (en) 2002-02-28
KR20010013901A (ko) 2001-02-26
ATE270341T1 (de) 2004-07-15
EP1032418B1 (en) 2004-06-30
EP1032418A4 (en) 2002-01-02
CA2293299A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
PT873405E (pt) Elementos de sequencia que aumentam a expressao (ease) para sistemas de expressao eucarioticos
ES2109924T3 (es) Metodo rapido, versatil y simple de expresion de genes en celulas eucarioticas.
AR009436A1 (es) UNA PROTEíNA DE FUSIoN FC-OB, UNA SECUENCIA DE ÁCIDO NUCLEICO QUE LA CODIFICA, UN VECTOR, PROCEDIMIENTO DE PREPARACIoN, COMPOSICIONES FARMACÉUTICAS Y USOS.
HK1039355A1 (en) Dna-protein fusions and uses thereof
ES2139087T3 (es) Inmunoensayos homogeneos que utilizan glucosa-6-fosfato-deshidrogenasas.
DE69013520D1 (de) Stabile integration von dna in bakterielle genome.
AU4065397A (en) Stable compositions for nucleic acid amplification and sequencing
NO931709D0 (no) Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon
BR9612258B1 (pt) inibidores de enzima conversora de interleucina-1beta, bem como composição farmacêutica.
ATE288480T1 (de) Chondrogene in vitro induktion von menschlichen mensenchymalen stammzellen
AR031912A2 (es) Subtilasa modificada, acido nucleico, vector, celula microbiana y metodo para producirla
AR070335A2 (es) Construcciones de adn de expresion en plantas que comprenden secuencias promotoras de arabidopsis thaliana y uso de las mismas
AU4049589A (en) Rna and dna amplification techniques
DK164596C (da) 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-quinolincarboxylsyrer, disse forbindelser til anvendelse til bekaempelse af sygdomme og deres anvendelse til fremstilling af et laegemiddel indeholdende dem
BR9610511B1 (pt) construções de dna, úteis em terapia genética, compreendendo ao menos uma sequência nucléica de interesse e composição farmacêutica.
PL340297A1 (en) Binary viral expression system in plants
NZ304570A (en) Neurone-restrictive silencer factor proteins, nucleic acids and antibodies thereto
NO20000097D0 (no) Isolerte dendrittcellemembranproteingener
DE69706648T2 (de) Verbinden von rohren zu gegenständen
EP1012603A4 (en) FUNCTIONAL FRAGMENTS OF THE HIV-1 VPR PROTEIN AND METHODS OF USE
DK0880539T3 (da) Nucleosidanaloger
PT1131408E (pt) Acidos oligossacarido-aldonicos e sua utilizacao topica
AR054291A1 (es) Replicas compactas de virus de epstein-barr
NO981322D0 (no) Farmasöytiske preparater for bruk ved nukleinsyretransfeksjon, og deres anvendelse
ITRM930199A0 (it) Metodo per desensibilizzare propellenti per razzi di scarto da smaltire.

Legal Events

Date Code Title Description
FB Suspension of granting procedure